Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 218

1.

Fatty acid transport protein 4 is required for incorporation of saturated ultralong-chain fatty acids into epidermal ceramides and monoacylglycerols.

Lin MH, Hsu FF, Crumrine D, Meyer J, Elias PM, Miner JH.

Sci Rep. 2019 Sep 13;9(1):13254. doi: 10.1038/s41598-019-49684-y.

2.

Alport Syndrome Therapeutics: Ready for Prime-Time Players.

Omachi K, Miner JH.

Trends Pharmacol Sci. 2019 Aug 24. pii: S0165-6147(19)30165-8. doi: 10.1016/j.tips.2019.07.012. [Epub ahead of print]

PMID:
31455555
3.

Dual lineage tracing shows that glomerular parietal epithelial cells can transdifferentiate toward the adult podocyte fate.

Kaverina NV, Eng DG, Freedman BS, Kutz JN, Chozinski TJ, Vaughan JC, Miner JH, Pippin JW, Shankland SJ.

Kidney Int. 2019 Sep;96(3):597-611. doi: 10.1016/j.kint.2019.03.014. Epub 2019 Mar 29.

PMID:
31200942
4.

The importance of clinician, patient and researcher collaborations in Alport syndrome.

Rheault MN, Savige J, Randles MJ, Weinstock A, Stepney M, Turner AN, Parziale G, Gross O, Flinter FA, Miner JH, Lagas S, Gear S, Lennon R.

Pediatr Nephrol. 2019 May 1. doi: 10.1007/s00467-019-04241-7. [Epub ahead of print] Review.

PMID:
31044288
5.

Mural cell-derived laminin-α5 plays a detrimental role in ischemic stroke.

Nirwane A, Johnson J, Nguyen B, Miner JH, Yao Y.

Acta Neuropathol Commun. 2019 Feb 18;7(1):23. doi: 10.1186/s40478-019-0676-8.

6.

Endothelial cell-specific collagen type IV-α3 expression does not rescue Alport syndrome in Col4a3-/- mice.

Funk SD, Bayer RH, Miner JH.

Am J Physiol Renal Physiol. 2019 May 1;316(5):F830-F837. doi: 10.1152/ajprenal.00556.2018. Epub 2019 Feb 6.

PMID:
30724107
7.

Loss of Endothelial Laminin α5 Exacerbates Hemorrhagic Brain Injury.

Gautam J, Miner JH, Yao Y.

Transl Stroke Res. 2019 Jan 29. doi: 10.1007/s12975-019-0688-5. [Epub ahead of print]

PMID:
30693425
8.

Mutations in Recessive Congenital Ichthyoses Illuminate the Origin and Functions of the Corneocyte Lipid Envelope.

Crumrine D, Khnykin D, Krieg P, Man MQ, Celli A, Mauro TM, Wakefield JS, Menon G, Mauldin E, Miner JH, Lin MH, Brash AR, Sprecher E, Radner FPW, Choate K, Roop D, Uchida Y, Gruber R, Schmuth M, Elias PM.

J Invest Dermatol. 2019 Apr;139(4):760-768. doi: 10.1016/j.jid.2018.11.005. Epub 2018 Nov 22.

PMID:
30471252
9.

Discs large 1 controls daughter-cell polarity after cytokinesis in vertebrate morphogenesis.

Li Y, Junge JA, Arnesano C, Gross GG, Miner JH, Moats R, Roberts RW, Arnold DB, Fraser SE.

Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10859-E10868. doi: 10.1073/pnas.1713959115. Epub 2018 Oct 30.

10.

What Is the Glomerular Ultrafiltration Barrier?

Fissell WH, Miner JH.

J Am Soc Nephrol. 2018 Sep;29(9):2262-2264. doi: 10.1681/ASN.2018050490. Epub 2018 Jul 20. Review. No abstract available.

11.

Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy.

Luo W, Olaru F, Miner JH, Beck LH Jr, van der Vlag J, Thurman JM, Borza DB.

Front Immunol. 2018 Jun 22;9:1433. doi: 10.3389/fimmu.2018.01433. eCollection 2018.

12.

Alport syndrome and Pierson syndrome: Diseases of the glomerular basement membrane.

Funk SD, Lin MH, Miner JH.

Matrix Biol. 2018 Oct;71-72:250-261. doi: 10.1016/j.matbio.2018.04.008. Epub 2018 Apr 16. Review.

13.

Systematic Analysis of Splice-Site-Creating Mutations in Cancer.

Jayasinghe RG, Cao S, Gao Q, Wendl MC, Vo NS, Reynolds SM, Zhao Y, Climente-González H, Chai S, Wang F, Varghese R, Huang M, Liang WW, Wyczalkowski MA, Sengupta S, Li Z, Payne SH, Fenyö D, Miner JH, Walter MJ; Cancer Genome Atlas Research Network, Vincent B, Eyras E, Chen K, Shmulevich I, Chen F, Ding L.

Cell Rep. 2018 Apr 3;23(1):270-281.e3. doi: 10.1016/j.celrep.2018.03.052.

14.

Homozygous KSR1 deletion attenuates morbidity but does not prevent tumor development in a mouse model of RAS-driven pancreatic cancer.

Germino EA, Miller JP, Diehl L, Swanson CJ, Durinck S, Modrusan Z, Miner JH, Shaw AS.

PLoS One. 2018 Mar 29;13(3):e0194998. doi: 10.1371/journal.pone.0194998. eCollection 2018.

15.

Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracing.

Eng DG, Kaverina NV, Schneider RRS, Freedman BS, Gross KW, Miner JH, Pippin JW, Shankland SJ.

Kidney Int. 2018 May;93(5):1240-1246. doi: 10.1016/j.kint.2018.01.014. Epub 2018 Mar 23.

16.

Laminin-521 Protein Therapy for Glomerular Basement Membrane and Podocyte Abnormalities in a Model of Pierson Syndrome.

Lin MH, Miller JB, Kikkawa Y, Suleiman HY, Tryggvason K, Hodges BL, Miner JH.

J Am Soc Nephrol. 2018 May;29(5):1426-1436. doi: 10.1681/ASN.2017060690. Epub 2018 Feb 22.

17.

Pathogenicity of a Human Laminin β2 Mutation Revealed in Models of Alport Syndrome.

Funk SD, Bayer RH, Malone AF, McKee KK, Yurchenco PD, Miner JH.

J Am Soc Nephrol. 2018 Mar;29(3):949-960. doi: 10.1681/ASN.2017090997. Epub 2017 Dec 20.

18.

Opposing Roles of Dendritic Cell Subsets in Experimental GN.

Brähler S, Zinselmeyer BH, Raju S, Nitschke M, Suleiman H, Saunders BT, Johnson MW, Böhner AMC, Viehmann SF, Theisen DJ, Kretzer NM, Briseño CG, Zaitsev K, Ornatsky O, Chang Q, Carrero JA, Kopp JB, Artyomov MN, Kurts C, Murphy KM, Miner JH, Shaw AS.

J Am Soc Nephrol. 2018 Jan;29(1):138-154. doi: 10.1681/ASN.2017030270. Epub 2017 Dec 7.

19.

B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement.

Kim AH, Chung JJ, Akilesh S, Koziell A, Jain S, Hodgin JB, Miller MJ, Stappenbeck TS, Miner JH, Shaw AS.

JCI Insight. 2017 Nov 2;2(21). pii: 81836. doi: 10.1172/jci.insight.81836.

20.

CNS Neurons Deposit Laminin α5 to Stabilize Synapses.

Omar MH, Kerrisk Campbell M, Xiao X, Zhong Q, Brunken WJ, Miner JH, Greer CA, Koleske AJ.

Cell Rep. 2017 Oct 31;21(5):1281-1292. doi: 10.1016/j.celrep.2017.10.028.

21.

Ultrastructural Characterization of the Glomerulopathy in Alport Mice by Helium Ion Scanning Microscopy (HIM).

Tsuji K, Suleiman H, Miner JH, Daley JM, Capen DE, Păunescu TG, Lu HAJ.

Sci Rep. 2017 Sep 15;7(1):11696. doi: 10.1038/s41598-017-12064-5.

22.

Glomerular mesangial cell recruitment and function require the co-receptor neuropilin-1.

Bartlett CS, Scott RP, Carota IA, Wnuk ML, Kanwar YS, Miner JH, Quaggin SE.

Am J Physiol Renal Physiol. 2017 Dec 1;313(6):F1232-F1242. doi: 10.1152/ajprenal.00311.2017. Epub 2017 Aug 23.

23.

Re-characterization of the Glomerulopathy in CD2AP Deficient Mice by High-Resolution Helium Ion Scanning Microscopy.

Tsuji K, Păunescu TG, Suleiman H, Xie D, Mamuya FA, Miner JH, Lu HAJ.

Sci Rep. 2017 Aug 16;7(1):8321. doi: 10.1038/s41598-017-08304-3.

24.

Injury-induced actin cytoskeleton reorganization in podocytes revealed by super-resolution microscopy.

Suleiman HY, Roth R, Jain S, Heuser JE, Shaw AS, Miner JH.

JCI Insight. 2017 Aug 17;2(16). pii: 94137. doi: 10.1172/jci.insight.94137. eCollection 2017 Aug 17.

25.

Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases.

Müller-Deile J, Dannenberg J, Schroder P, Lin MH, Miner JH, Chen R, Bräsen JH, Thum T, Nyström J, Staggs LB, Haller H, Fiedler J, Lorenzen JM, Schiffer M.

Kidney Int. 2017 Oct;92(4):836-849. doi: 10.1016/j.kint.2017.03.005. Epub 2017 May 3.

26.

Permeation of macromolecules into the renal glomerular basement membrane and capture by the tubules.

Lawrence MG, Altenburg MK, Sanford R, Willett JD, Bleasdale B, Ballou B, Wilder J, Li F, Miner JH, Berg UB, Smithies O.

Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):2958-2963. doi: 10.1073/pnas.1616457114. Epub 2017 Feb 28.

27.

Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Beckerman P, Bi-Karchin J, Park AS, Qiu C, Dummer PD, Soomro I, Boustany-Kari CM, Pullen SS, Miner JH, Hu CA, Rohacs T, Inoue K, Ishibe S, Saleem MA, Palmer MB, Cuervo AM, Kopp JB, Susztak K.

Nat Med. 2017 Apr;23(4):429-438. doi: 10.1038/nm.4287. Epub 2017 Feb 20.

28.

Muscular dystrophy meets protein biochemistry, the mother of invention.

Funk SD, Miner JH.

J Clin Invest. 2017 Mar 1;127(3):798-800. doi: 10.1172/JCI92847. Epub 2017 Feb 20.

29.

Linear ion-trap MSn with high-resolution MS reveals structural diversity of 1-O-acylceramide family in mouse epidermis.

Lin MH, Miner JH, Turk J, Hsu FF.

J Lipid Res. 2017 Apr;58(4):772-782. doi: 10.1194/jlr.D071647. Epub 2017 Feb 2.

30.

Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.

Malone AF, Funk SD, Alhamad T, Miner JH.

Pediatr Nephrol. 2017 Jun;32(6):997-1003. doi: 10.1007/s00467-016-3565-4. Epub 2016 Dec 24.

31.

Intravital and Kidney Slice Imaging of Podocyte Membrane Dynamics.

Brähler S, Yu H, Suleiman H, Krishnan GM, Saunders BT, Kopp JB, Miner JH, Zinselmeyer BH, Shaw AS.

J Am Soc Nephrol. 2016 Nov;27(11):3285-3290. Epub 2016 Apr 1.

32.

Three-dimensional electron microscopy reveals the evolution of glomerular barrier injury.

Randles MJ, Collinson S, Starborg T, Mironov A, Krendel M, Königshausen E, Sellin L, Roberts IS, Kadler KE, Miner JH, Lennon R.

Sci Rep. 2016 Oct 11;6:35068. doi: 10.1038/srep35068.

33.

A flexible, multilayered protein scaffold maintains the slit in between glomerular podocytes.

Grahammer F, Wigge C, Schell C, Kretz O, Patrakka J, Schneider S, Klose M, Kind J, Arnold SJ, Habermann A, Bräuniger R, Rinschen MM, Völker L, Bregenzer A, Rubbenstroth D, Boerries M, Kerjaschki D, Miner JH, Walz G, Benzing T, Fornoni A, Frangakis AS, Huber TB.

JCI Insight. 2016 Jun 16;1(9). pii: 86177. doi: 10.1172/jci.insight.86177.

34.

Requirement for basement membrane laminin α5 during urethral and external genital development.

Lin C, Werner R, Ma L, Miner JH.

Mech Dev. 2016 Aug;141:62-69. doi: 10.1016/j.mod.2016.05.004. Epub 2016 May 18.

35.

Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome.

Gross O, Kashtan CE, Rheault MN, Flinter F, Savige J, Miner JH, Torra R, Ars E, Deltas C, Savva I, Perin L, Renieri A, Ariani F, Mari F, Baigent C, Judge P, Knebelman B, Heidet L, Lagas S, Blatt D, Ding J, Zhang Y, Gale DP, Prunotto M, Xue Y, Schachter AD, Morton LCG, Blem J, Huang M, Liu S, Vallee S, Renault D, Schifter J, Skelding J, Gear S, Friede T, Turner AN, Lennon R.

Nephrol Dial Transplant. 2017 Jun 1;32(6):916-924. doi: 10.1093/ndt/gfw095.

36.

Albumin contributes to kidney disease progression in Alport syndrome.

Jarad G, Knutsen RH, Mecham RP, Miner JH.

Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F120-30. doi: 10.1152/ajprenal.00456.2015. Epub 2016 May 4.

37.

Mesencephalic Astrocyte-Derived Neurotrophic Factor as a Urine Biomarker for Endoplasmic Reticulum Stress-Related Kidney Diseases.

Kim Y, Lee H, Manson SR, Lindahl M, Evans B, Miner JH, Urano F, Chen YM.

J Am Soc Nephrol. 2016 Oct;27(10):2974-2982. Epub 2016 Mar 3.

38.

A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.

Yu H, Artomov M, Brähler S, Stander MC, Shamsan G, Sampson MG, White JM, Kretzler M, Miner JH, Jain S, Winkler CA, Mitra RD, Kopp JB, Daly MJ, Shaw AS.

J Clin Invest. 2016 Apr 1;126(4):1603. doi: 10.1172/JCI87342. Epub 2016 Mar 1. No abstract available.

39.

A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.

Yu H, Artomov M, Brähler S, Stander MC, Shamsan G, Sampson MG, White JM, Kretzler M, Miner JH, Jain S, Winkler CA, Mitra RD, Kopp JB, Daly MJ, Shaw AS.

J Clin Invest. 2016 Mar 1;126(3):1067-78. doi: 10.1172/JCI82592. Epub 2016 Feb 22. Erratum in: J Clin Invest. 2016 Apr 1;126(4):1603.

40.

Preface.

Miner JH.

Curr Top Membr. 2016;77:xi-xiv. doi: 10.1016/S1063-5823(16)00010-7. No abstract available.

PMID:
26781834
41.

Podocyte biology in 2015: New insights into the mechanisms of podocyte health.

Miner JH.

Nat Rev Nephrol. 2016 Feb;12(2):63-4. doi: 10.1038/nrneph.2015.204. Epub 2015 Dec 21. No abstract available.

PMID:
26685913
42.

Preface.

Miner JH.

Curr Top Membr. 2015;76:xi-xiv. doi: 10.1016/S1063-5823(15)00079-4. No abstract available.

PMID:
26610920
43.

Albumin-associated free fatty acids induce macropinocytosis in podocytes.

Chung JJ, Huber TB, Gödel M, Jarad G, Hartleben B, Kwoh C, Keil A, Karpitskiy A, Hu J, Huh CJ, Cella M, Gross RW, Miner JH, Shaw AS.

J Clin Invest. 2015 Jun;125(6):2307-16. doi: 10.1172/JCI79641. Epub 2015 Apr 27.

44.

Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome.

Miner JH.

Kidney Int. 2014 Dec;86(6):1081-3. doi: 10.1038/ki.2014.326.

45.

Fatty acid transport protein 1 can compensate for fatty acid transport protein 4 in the developing mouse epidermis.

Lin MH, Miner JH.

J Invest Dermatol. 2015 Feb;135(2):462-470. doi: 10.1038/jid.2014.378. Epub 2014 Sep 3.

46.

The 2014International Workshop on Alport Syndrome.

Miner JH, Baigent C, Flinter F, Gross O, Judge P, Kashtan CE, Lagas S, Savige J, Blatt D, Ding J, Gale DP, Midgley JP, Povey S, Prunotto M, Renault D, Skelding J, Turner AN, Gear S.

Kidney Int. 2014 Oct;86(4):679-84. doi: 10.1038/ki.2014.229. Epub 2014 Jul 2.

47.

Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS.

Maezawa Y, Onay T, Scott RP, Keir LS, Dimke H, Li C, Eremina V, Maezawa Y, Jeansson M, Shan J, Binnie M, Lewin M, Ghosh A, Miner JH, Vainio SJ, Quaggin SE.

J Am Soc Nephrol. 2014 Nov;25(11):2459-70. doi: 10.1681/ASN.2013121307. Epub 2014 Jun 5.

48.

Laminin α1 regulates age-related mesangial cell proliferation and mesangial matrix accumulation through the TGF-β pathway.

Ning L, Kurihara H, de Vega S, Ichikawa-Tomikawa N, Xu Z, Nonaka R, Kazuno S, Yamada Y, Miner JH, Arikawa-Hirasawa E.

Am J Pathol. 2014 Jun;184(6):1683-94. doi: 10.1016/j.ajpath.2014.02.006. Epub 2014 Apr 8.

49.

DLG1 influences distal ureter maturation via a non-epithelial cell autonomous mechanism involving reduced retinoic acid signaling, Ret expression, and apoptosis.

Kim ST, Ahn SY, Swat W, Miner JH.

Dev Biol. 2014 Jun 15;390(2):160-9. doi: 10.1016/j.ydbio.2014.03.014. Epub 2014 Mar 31.

50.

A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.

Korstanje R, Caputo CR, Doty RA, Cook SA, Bronson RT, Davisson MT, Miner JH.

Kidney Int. 2014 Jun;85(6):1461-8. doi: 10.1038/ki.2013.493. Epub 2014 Feb 12.

Supplemental Content

Loading ...
Support Center